Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 11 | 2024 | 1551 | 1.280 |
Why?
|
Fluorocarbons | 5 | 2023 | 492 | 1.200 |
Why?
|
Prenatal Exposure Delayed Effects | 6 | 2021 | 2518 | 1.120 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2023 | 226 | 1.060 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 7 | 2023 | 382 | 0.900 |
Why?
|
Environmental Pollutants | 4 | 2023 | 1277 | 0.850 |
Why?
|
Alkanesulfonic Acids | 3 | 2023 | 201 | 0.840 |
Why?
|
Leukemia, Biphenotypic, Acute | 2 | 2019 | 32 | 0.820 |
Why?
|
Leukemia | 6 | 2021 | 1522 | 0.750 |
Why?
|
Oncogene Proteins, Fusion | 6 | 2024 | 1606 | 0.700 |
Why?
|
Fibrosarcoma | 2 | 2020 | 309 | 0.660 |
Why?
|
Environmental Exposure | 5 | 2023 | 4486 | 0.640 |
Why?
|
Gene Rearrangement | 2 | 2021 | 1125 | 0.610 |
Why?
|
Nephroma, Mesoblastic | 1 | 2017 | 24 | 0.600 |
Why?
|
Air Pollutants | 3 | 2023 | 2896 | 0.460 |
Why?
|
Executive Function | 3 | 2021 | 1389 | 0.460 |
Why?
|
Nutrition Surveys | 2 | 2021 | 1733 | 0.450 |
Why?
|
Vehicle Emissions | 2 | 2016 | 656 | 0.440 |
Why?
|
Serine Endopeptidases | 1 | 2017 | 1022 | 0.410 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1076 | 0.400 |
Why?
|
Cognition | 3 | 2018 | 6990 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2024 | 225 | 0.360 |
Why?
|
Child | 41 | 2024 | 80153 | 0.340 |
Why?
|
Sequence Analysis, RNA | 4 | 2023 | 2020 | 0.340 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2022 | 3613 | 0.340 |
Why?
|
High-Throughput Nucleotide Sequencing | 8 | 2024 | 3639 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 7 | 2005 | 1405 | 0.330 |
Why?
|
Bone Marrow Diseases | 1 | 2010 | 233 | 0.310 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 3448 | 0.300 |
Why?
|
Genomics | 5 | 2023 | 5821 | 0.290 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 3 | 2022 | 305 | 0.290 |
Why?
|
Soft Tissue Neoplasms | 3 | 2021 | 1159 | 0.280 |
Why?
|
Histone-Lysine N-Methyltransferase | 4 | 2022 | 682 | 0.280 |
Why?
|
Neoplasms | 7 | 2024 | 22170 | 0.270 |
Why?
|
Neoplasm, Residual | 3 | 2020 | 1008 | 0.270 |
Why?
|
Translocation, Genetic | 3 | 2024 | 1393 | 0.260 |
Why?
|
Intracellular Membranes | 3 | 2003 | 389 | 0.260 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9280 | 0.260 |
Why?
|
Child, Preschool | 23 | 2024 | 42230 | 0.250 |
Why?
|
Bone Marrow Cells | 2 | 2010 | 2416 | 0.240 |
Why?
|
Kidney Neoplasms | 2 | 2021 | 4249 | 0.240 |
Why?
|
Proto-Oncogene Proteins | 7 | 2024 | 4511 | 0.230 |
Why?
|
Torque teno virus | 1 | 2024 | 13 | 0.230 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2021 | 2510 | 0.220 |
Why?
|
Oxidative Phosphorylation | 4 | 2008 | 496 | 0.220 |
Why?
|
Adrenoleukodystrophy | 1 | 2024 | 143 | 0.200 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2024 | 251 | 0.200 |
Why?
|
Infant | 19 | 2022 | 36192 | 0.200 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1896 | 0.200 |
Why?
|
Mitochondria | 7 | 2005 | 3624 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2018 | 2825 | 0.200 |
Why?
|
Lentivirus | 1 | 2024 | 508 | 0.190 |
Why?
|
Asparaginase | 3 | 2021 | 240 | 0.190 |
Why?
|
Myelodysplastic Syndromes | 3 | 2024 | 1394 | 0.190 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 42 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2023 | 314 | 0.190 |
Why?
|
Medical Oncology | 1 | 2013 | 2321 | 0.190 |
Why?
|
Sarcoma, Clear Cell | 1 | 2021 | 72 | 0.180 |
Why?
|
Repressor Proteins | 3 | 2021 | 2986 | 0.180 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 180 | 0.180 |
Why?
|
Blood Group Antigens | 1 | 2022 | 184 | 0.180 |
Why?
|
Humans | 69 | 2024 | 761504 | 0.170 |
Why?
|
Neoplastic Stem Cells | 2 | 2021 | 1347 | 0.170 |
Why?
|
Pregnancy | 9 | 2023 | 29874 | 0.170 |
Why?
|
Ikaros Transcription Factor | 2 | 2018 | 232 | 0.170 |
Why?
|
Air Pollution | 2 | 2023 | 2359 | 0.170 |
Why?
|
Mutation | 13 | 2023 | 30052 | 0.170 |
Why?
|
Myofibroma | 1 | 2019 | 45 | 0.170 |
Why?
|
Tissue Banks | 2 | 2020 | 184 | 0.170 |
Why?
|
Remission Induction | 3 | 2020 | 2396 | 0.160 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2021 | 651 | 0.160 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 1 | 2019 | 146 | 0.160 |
Why?
|
Fasciitis | 1 | 2019 | 67 | 0.160 |
Why?
|
Cell Membrane Permeability | 1 | 2000 | 575 | 0.160 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 184 | 0.160 |
Why?
|
Pyruvate Kinase | 2 | 2012 | 189 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2021 | 11742 | 0.160 |
Why?
|
Protein Isoforms | 1 | 2023 | 1699 | 0.150 |
Why?
|
Gene Duplication | 2 | 2022 | 314 | 0.150 |
Why?
|
Galectins | 1 | 2021 | 295 | 0.150 |
Why?
|
Parotid Neoplasms | 1 | 2019 | 157 | 0.150 |
Why?
|
Resource Allocation | 1 | 2020 | 350 | 0.150 |
Why?
|
Pediatrics | 1 | 2013 | 3589 | 0.150 |
Why?
|
Immune Evasion | 1 | 2021 | 363 | 0.150 |
Why?
|
Lymphoma, T-Cell | 1 | 2020 | 304 | 0.140 |
Why?
|
Interleukin-3 | 6 | 2005 | 425 | 0.140 |
Why?
|
Polyethylene Glycols | 3 | 2021 | 1189 | 0.140 |
Why?
|
Adolescent | 20 | 2024 | 88319 | 0.140 |
Why?
|
Mothers | 2 | 2018 | 2198 | 0.140 |
Why?
|
Scalp | 1 | 2019 | 389 | 0.140 |
Why?
|
Glycolysis | 7 | 2008 | 835 | 0.140 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 455 | 0.140 |
Why?
|
Sequence Deletion | 3 | 2018 | 1494 | 0.130 |
Why?
|
Pathology, Molecular | 1 | 2019 | 328 | 0.130 |
Why?
|
Female | 37 | 2024 | 392644 | 0.130 |
Why?
|
Proteins | 2 | 2010 | 6032 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 702 | 0.130 |
Why?
|
Apoptosis | 8 | 2005 | 9486 | 0.130 |
Why?
|
Genetic Testing | 2 | 2019 | 3537 | 0.120 |
Why?
|
Pesticides | 1 | 2018 | 296 | 0.120 |
Why?
|
Skull | 1 | 2019 | 818 | 0.120 |
Why?
|
Linear Models | 4 | 2018 | 5871 | 0.120 |
Why?
|
Gene Fusion | 1 | 2018 | 356 | 0.120 |
Why?
|
Male | 39 | 2024 | 360804 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2024 | 2425 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1768 | 0.120 |
Why?
|
Genetic Vectors | 1 | 2024 | 3395 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2019 | 805 | 0.120 |
Why?
|
DNA Copy Number Variations | 3 | 2019 | 2020 | 0.120 |
Why?
|
Oncogenes | 3 | 2021 | 1222 | 0.120 |
Why?
|
HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
Wilms Tumor | 1 | 2017 | 379 | 0.110 |
Why?
|
Environmental Monitoring | 2 | 2023 | 1460 | 0.110 |
Why?
|
Hedgehog Proteins | 1 | 2018 | 768 | 0.110 |
Why?
|
Anemia, Aplastic | 1 | 2015 | 230 | 0.100 |
Why?
|
Carbon | 2 | 2015 | 666 | 0.100 |
Why?
|
Chromosome Breakage | 1 | 2013 | 159 | 0.100 |
Why?
|
Transplants | 1 | 2015 | 206 | 0.100 |
Why?
|
Enzyme Activators | 1 | 2012 | 57 | 0.100 |
Why?
|
Pregnancy Trimester, Second | 1 | 2015 | 731 | 0.100 |
Why?
|
Breast Feeding | 2 | 2023 | 1359 | 0.100 |
Why?
|
Exons | 4 | 2023 | 2391 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2021 | 3602 | 0.100 |
Why?
|
Lymphoma, Follicular | 1 | 2016 | 457 | 0.100 |
Why?
|
Biopolymers | 1 | 2012 | 184 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2022 | 26198 | 0.100 |
Why?
|
Fetal Blood | 1 | 2018 | 1347 | 0.100 |
Why?
|
Esophageal Perforation | 1 | 2011 | 65 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 1 | 2015 | 531 | 0.090 |
Why?
|
Pregnancy Trimester, First | 1 | 2015 | 907 | 0.090 |
Why?
|
Treatment Failure | 2 | 2014 | 2645 | 0.090 |
Why?
|
Cell Proliferation | 5 | 2014 | 10445 | 0.090 |
Why?
|
Child Behavior | 1 | 2016 | 847 | 0.090 |
Why?
|
Genes, Fungal | 2 | 2002 | 439 | 0.090 |
Why?
|
Down Syndrome | 1 | 2018 | 901 | 0.090 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2449 | 0.080 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 1 | 2011 | 168 | 0.080 |
Why?
|
Immunocompromised Host | 1 | 2015 | 856 | 0.080 |
Why?
|
Lysine | 1 | 2014 | 993 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1486 | 0.080 |
Why?
|
Chromosome Segregation | 1 | 2010 | 235 | 0.080 |
Why?
|
Centrosome | 1 | 2010 | 209 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1866 | 0.080 |
Why?
|
Escherichia coli Proteins | 1 | 2015 | 1067 | 0.080 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2015 | 612 | 0.080 |
Why?
|
Particulate Matter | 2 | 2023 | 2605 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2018 | 2093 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2014 | 988 | 0.080 |
Why?
|
bcl-2-Associated X Protein | 4 | 2005 | 282 | 0.080 |
Why?
|
Young Adult | 10 | 2022 | 59243 | 0.080 |
Why?
|
Brain Neoplasms | 2 | 2021 | 9031 | 0.070 |
Why?
|
Thrombosis | 1 | 2022 | 2942 | 0.070 |
Why?
|
Intestinal Perforation | 1 | 2010 | 249 | 0.070 |
Why?
|
Glucose | 5 | 2004 | 4346 | 0.070 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2010 | 212 | 0.070 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 3802 | 0.070 |
Why?
|
Intestinal Neoplasms | 1 | 2010 | 312 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2019 | 11076 | 0.070 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26125 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2529 | 0.070 |
Why?
|
Growth Substances | 3 | 2005 | 768 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1901 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2803 | 0.070 |
Why?
|
DNA Methylation | 2 | 2018 | 4398 | 0.070 |
Why?
|
Natural Killer T-Cells | 1 | 2010 | 322 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2898 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39106 | 0.070 |
Why?
|
Carcinoma | 1 | 2017 | 2330 | 0.070 |
Why?
|
Sequence Analysis, DNA | 4 | 2019 | 4740 | 0.070 |
Why?
|
Mice | 19 | 2023 | 81525 | 0.070 |
Why?
|
Granulocytes | 1 | 2008 | 551 | 0.060 |
Why?
|
Adult | 12 | 2024 | 221177 | 0.060 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2020 | 857 | 0.060 |
Why?
|
Signal Transduction | 5 | 2024 | 23445 | 0.060 |
Why?
|
Stem Cells | 3 | 2010 | 3522 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2024 | 12690 | 0.060 |
Why?
|
Bone Marrow | 1 | 2015 | 2911 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3429 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5796 | 0.060 |
Why?
|
Molecular Targeted Therapy | 3 | 2022 | 2811 | 0.060 |
Why?
|
Prognosis | 6 | 2021 | 29625 | 0.060 |
Why?
|
Syndrome | 1 | 2010 | 3267 | 0.060 |
Why?
|
Child Development | 1 | 2016 | 2306 | 0.060 |
Why?
|
Neoplasm Transplantation | 3 | 2016 | 2016 | 0.060 |
Why?
|
Transcription Factors | 1 | 2023 | 12128 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2928 | 0.060 |
Why?
|
Environmental Policy | 1 | 2023 | 35 | 0.060 |
Why?
|
Animals | 22 | 2023 | 168459 | 0.060 |
Why?
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2003 | 22 | 0.060 |
Why?
|
Interleukin-7 | 1 | 2004 | 143 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2580 | 0.060 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 13639 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1827 | 0.060 |
Why?
|
Receptor, trkA | 1 | 2024 | 159 | 0.050 |
Why?
|
Escherichia coli | 1 | 2015 | 4217 | 0.050 |
Why?
|
MicroRNAs | 2 | 2010 | 3816 | 0.050 |
Why?
|
Climate | 1 | 2023 | 147 | 0.050 |
Why?
|
Cohort Studies | 4 | 2021 | 41487 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2008 | 1093 | 0.050 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10194 | 0.050 |
Why?
|
Cytochromes c | 1 | 2003 | 173 | 0.050 |
Why?
|
Environmental Pollution | 1 | 2023 | 124 | 0.050 |
Why?
|
Immunophenotyping | 2 | 2018 | 1870 | 0.050 |
Why?
|
Alleles | 3 | 2022 | 6863 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2015 | 4174 | 0.050 |
Why?
|
Massachusetts | 1 | 2015 | 8830 | 0.050 |
Why?
|
Oxygen Consumption | 3 | 2008 | 1866 | 0.050 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 368 | 0.050 |
Why?
|
Research Design | 2 | 2016 | 6180 | 0.050 |
Why?
|
Lactation | 1 | 2023 | 397 | 0.050 |
Why?
|
United States | 5 | 2023 | 72334 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3530 | 0.050 |
Why?
|
Nitrogen Dioxide | 1 | 2023 | 522 | 0.050 |
Why?
|
Voltage-Dependent Anion Channels | 1 | 2000 | 15 | 0.050 |
Why?
|
Survival Analysis | 3 | 2019 | 10090 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4758 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 2 | 2002 | 2688 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2014 | 431 | 0.040 |
Why?
|
Oncogene Fusion | 1 | 2020 | 81 | 0.040 |
Why?
|
Porins | 1 | 2000 | 78 | 0.040 |
Why?
|
Cytosol | 1 | 2003 | 888 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2872 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2024 | 16981 | 0.040 |
Why?
|
Codon | 1 | 2021 | 601 | 0.040 |
Why?
|
Electron Transport | 1 | 2000 | 210 | 0.040 |
Why?
|
Recurrence | 3 | 2019 | 8465 | 0.040 |
Why?
|
Age Factors | 4 | 2018 | 18395 | 0.040 |
Why?
|
Growth Inhibitors | 1 | 2000 | 378 | 0.040 |
Why?
|
Prospective Studies | 3 | 2022 | 54425 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2019 | 740 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 347 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 58976 | 0.040 |
Why?
|
DNA Primers | 2 | 2014 | 2819 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2019 | 337 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4414 | 0.040 |
Why?
|
Radiation Tolerance | 1 | 2019 | 479 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2004 | 1889 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2020 | 10209 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8002 | 0.030 |
Why?
|
Middle Aged | 7 | 2024 | 220895 | 0.030 |
Why?
|
Autophagy | 1 | 2005 | 1326 | 0.030 |
Why?
|
Agriculture | 1 | 2018 | 191 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 23995 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12725 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6814 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 601 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6484 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2019 | 1693 | 0.030 |
Why?
|
Lymphocytes | 1 | 2004 | 2612 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1626 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2116 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2017 | 473 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2019 | 764 | 0.030 |
Why?
|
Vincristine | 1 | 2018 | 1036 | 0.030 |
Why?
|
Biological Transport | 1 | 2000 | 2091 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2018 | 883 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2000 | 868 | 0.030 |
Why?
|
Drug Therapy | 1 | 2018 | 503 | 0.030 |
Why?
|
Cell Survival | 3 | 2001 | 5791 | 0.030 |
Why?
|
Sulfonic Acids | 1 | 2015 | 103 | 0.030 |
Why?
|
Cell Shape | 1 | 2016 | 371 | 0.030 |
Why?
|
bcl-X Protein | 3 | 2002 | 410 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2024 | 5671 | 0.030 |
Why?
|
Caprylates | 1 | 2015 | 115 | 0.030 |
Why?
|
Cell Division | 4 | 2004 | 4465 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2021 | 1188 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2019 | 1080 | 0.030 |
Why?
|
Disease Progression | 2 | 2022 | 13506 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 413 | 0.030 |
Why?
|
Aerobiosis | 2 | 2004 | 100 | 0.030 |
Why?
|
Isoquinolines | 1 | 2016 | 352 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2015 | 554 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2018 | 1596 | 0.030 |
Why?
|
Boston | 2 | 2018 | 9326 | 0.030 |
Why?
|
California | 1 | 2018 | 1429 | 0.030 |
Why?
|
Ethanol | 1 | 2000 | 1324 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2014 | 228 | 0.030 |
Why?
|
Genes, p53 | 1 | 2016 | 712 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 368 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6132 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1563 | 0.030 |
Why?
|
Pyruvic Acid | 2 | 2008 | 204 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1702 | 0.030 |
Why?
|
Aged | 4 | 2021 | 169289 | 0.030 |
Why?
|
Gene Dosage | 1 | 2017 | 1217 | 0.030 |
Why?
|
Phenotype | 4 | 2016 | 16591 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 12974 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2015 | 15631 | 0.030 |
Why?
|
Maternal Age | 1 | 2015 | 809 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2726 | 0.030 |
Why?
|
Parity | 1 | 2015 | 927 | 0.030 |
Why?
|
Gene Frequency | 1 | 2019 | 3606 | 0.020 |
Why?
|
Fractures, Bone | 1 | 2024 | 2046 | 0.020 |
Why?
|
Metabolomics | 1 | 2021 | 1659 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2024 | 15936 | 0.020 |
Why?
|
Random Allocation | 1 | 2016 | 2395 | 0.020 |
Why?
|
Methylation | 1 | 2014 | 1084 | 0.020 |
Why?
|
Doxorubicin | 1 | 2018 | 2224 | 0.020 |
Why?
|
Mice, Inbred C57BL | 4 | 2014 | 22169 | 0.020 |
Why?
|
Base Sequence | 2 | 2014 | 12441 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3734 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 2 | 2002 | 186 | 0.020 |
Why?
|
Protein Kinases | 1 | 2018 | 1608 | 0.020 |
Why?
|
Risk Factors | 4 | 2022 | 74206 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2601 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 487 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6534 | 0.020 |
Why?
|
Skin Neoplasms | 1 | 2010 | 5821 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 21012 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2122 | 0.020 |
Why?
|
Lipids | 1 | 2021 | 3341 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5247 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10766 | 0.020 |
Why?
|
Monosaccharide Transport Proteins | 2 | 2002 | 436 | 0.020 |
Why?
|
Adenosine Diphosphate | 2 | 2002 | 422 | 0.020 |
Why?
|
Esophagoscopy | 1 | 2011 | 396 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1408 | 0.020 |
Why?
|
Skin Diseases, Bacterial | 1 | 2010 | 68 | 0.020 |
Why?
|
Social Behavior | 1 | 2016 | 1135 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2010 | 362 | 0.020 |
Why?
|
Neurons | 2 | 2010 | 9463 | 0.020 |
Why?
|
Glioblastoma | 1 | 2004 | 3482 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2018 | 2057 | 0.020 |
Why?
|
Fructosediphosphates | 1 | 2008 | 24 | 0.020 |
Why?
|
Herpesviridae Infections | 1 | 2010 | 270 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6766 | 0.020 |
Why?
|
Cell Line | 4 | 2003 | 15601 | 0.020 |
Why?
|
Myogenic Regulatory Factors | 1 | 2008 | 103 | 0.020 |
Why?
|
Nose Neoplasms | 1 | 2010 | 249 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1509 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2014 | 18965 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 1749 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2555 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7856 | 0.020 |
Why?
|
Zebrafish | 1 | 2018 | 3007 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9606 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4812 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2014 | 2693 | 0.020 |
Why?
|
Microcephaly | 1 | 2010 | 425 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2008 | 14414 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2014 | 9539 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5305 | 0.020 |
Why?
|
Proteome | 1 | 2016 | 1862 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2523 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2018 | 64680 | 0.020 |
Why?
|
Mitosis | 1 | 2010 | 1187 | 0.020 |
Why?
|
Blotting, Western | 1 | 2012 | 5035 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12059 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2005 | 237 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2004 | 2455 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2010 | 1078 | 0.010 |
Why?
|
Cycloheximide | 1 | 2004 | 343 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2020 | 80636 | 0.010 |
Why?
|
Time Factors | 2 | 2016 | 39967 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3617 | 0.010 |
Why?
|
Emotions | 1 | 2016 | 2739 | 0.010 |
Why?
|
Internet | 1 | 2016 | 3092 | 0.010 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2003 | 71 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2004 | 2865 | 0.010 |
Why?
|
Neurogenesis | 1 | 2010 | 863 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6075 | 0.010 |
Why?
|
Rotenone | 1 | 2003 | 45 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 2000 | 1989 | 0.010 |
Why?
|
Succinates | 1 | 2003 | 81 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20098 | 0.010 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2005 | 695 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2004 | 867 | 0.010 |
Why?
|
Lateral Ventricles | 1 | 2003 | 146 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2014 | 5789 | 0.010 |
Why?
|
Lactic Acid | 1 | 2008 | 1139 | 0.010 |
Why?
|
Cell Respiration | 1 | 2003 | 201 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7237 | 0.010 |
Why?
|
Fermentation | 1 | 2002 | 146 | 0.010 |
Why?
|
Binding Sites | 2 | 2002 | 6055 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 6216 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2003 | 5869 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7827 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3615 | 0.010 |
Why?
|
RNA, Viral | 1 | 2010 | 2846 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17635 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12463 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2003 | 910 | 0.010 |
Why?
|
Anemia | 1 | 2010 | 1509 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2000 | 2547 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2665 | 0.010 |
Why?
|
Cells | 1 | 2001 | 165 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5671 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9420 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2002 | 685 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2003 | 1090 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2003 | 2561 | 0.010 |
Why?
|
Cell Count | 1 | 2003 | 1835 | 0.010 |
Why?
|
Lysosomes | 1 | 2005 | 924 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4003 | 0.010 |
Why?
|
S Phase | 1 | 2000 | 421 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2002 | 1229 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22176 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2008 | 11528 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15266 | 0.010 |
Why?
|
Cell Size | 1 | 2000 | 624 | 0.010 |
Why?
|
Interphase | 1 | 1999 | 228 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2004 | 3597 | 0.010 |
Why?
|
Dimerization | 1 | 1999 | 891 | 0.010 |
Why?
|
Molecular Chaperones | 1 | 2002 | 754 | 0.010 |
Why?
|
Benzamides | 1 | 2003 | 1370 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2000 | 563 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2011 | 11121 | 0.010 |
Why?
|
Cerebellum | 1 | 2003 | 1501 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5774 | 0.010 |
Why?
|
Temperature | 1 | 2002 | 2226 | 0.010 |
Why?
|
Atrophy | 1 | 2000 | 1633 | 0.010 |
Why?
|
Neutrophils | 1 | 2008 | 3767 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2010 | 12795 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2011 | 6485 | 0.010 |
Why?
|
Liver | 1 | 2010 | 7529 | 0.010 |
Why?
|
Quality of Life | 1 | 2015 | 13367 | 0.010 |
Why?
|
Ligands | 1 | 2000 | 3272 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2002 | 1841 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1999 | 3792 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8547 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 4369 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2002 | 5486 | 0.010 |
Why?
|
Peptides | 1 | 2003 | 4358 | 0.010 |
Why?
|
Homeostasis | 1 | 2002 | 3323 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2000 | 2416 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 18252 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2000 | 2882 | 0.010 |
Why?
|
Lung | 1 | 2008 | 10000 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 10773 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2011 | 20570 | 0.000 |
Why?
|
Gene Expression | 1 | 2000 | 7581 | 0.000 |
Why?
|
Protein Binding | 1 | 1999 | 9351 | 0.000 |
Why?
|
Cytokines | 1 | 1999 | 7396 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 2008 | 13380 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9469 | 0.000 |
Why?
|